… the Akt expression in pancreatic cancer (P < .001) while PI3K inhibitor LY294002 can reverse
this process (P < .001). (D) Akt … (E) Pancreatic cancer cell apoptosis was detected by Flow …

… of pancreatic cancer cells. We suggest that interfering with the functions of IGF-1/PI3K/Akt/NF…
кB might be a novel therapeutic approach to inhibit aggressive spread of pancreatic cancer. …

… Therefore, given the preliminary cellular studies that demonstrate that the inhibition of
PI3K/AKT sensitises pancreatic cancer to the apoptotic effect of chemotherapy, we sought to …

… in cervical cancer tissues, but also in several other cancers … role of HCCR-1 in
pancreatic cancer development. Here in this … for pancreatic cancer via EGF mediated-PI3K/Akt/mTOR …

… of the PI3K/Akt pathway in invasiveness of pancreatic cancer … In the present study, we
explored the role of the PI3K/Akt … of pancreatic cancer through the recruitment of the PI3K/Akt …

… pancreatic tumor angiogenesis and tumor growth by targeting the VEGFR2-mediated PI3K/Akt/…
hispidulin could be a potential drug candidate for cancer prevention and cancer therapy. …

… could enhance tumorigenesis and induce tumor development in a variety of … PI3K/Akt
signaling has been frequently upregulated in various types of cancer (20), plays a key role in tumor …

… /protein kinase B (PI3K/AKT) signaling pathway. CONCLUSIONS: … PI3K/AKT signaling
pathway by targeting PTEN, which provided a potential therapeutic target for pancreatic cancer …

… the protein expression of p62, PI3K, Akt, p‑PI3K and p‑Akt was decreased. These findings
… , PI3K/Akt signaling molecules may have potential therapeutic targets in pancreatic cancer (…

… /mTOR signaling pathway, we examined the levels of PTEN, PI3K, Akt, and mTOR mRNA
expression in pancreatic cancer tissue and spontaneous liver metastases after treatment with …